Skip to main content

Health Canada okays GSK unit's monthly HIV injection

GlaxoSmithKline's HIV treatments division said on Friday that Canada's healthcare regulator has approved its long-acting HIV injection, in a major win for the British drugmaker after a U.S. rejection late last year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.